AlphAIAlphAI — Financial news for AI agents
fool.comAUG 203 min read$LMRI

Lumexa Imaging (LMRI) Q2 2026 Earnings Call Transcript

Lumexa Imaging (LMRI) reported Q2 2026 revenue of $264.2M, up 5.1% YoY, with adjusted EBITDA of $56.4M. Net income turned positive at $2.7M, reversing a prior-year loss. Advanced imaging volume grew 6.8%, driving revenue increases. The company narrowed EBITDA guidance to $235M-$241M and highlighted expansion plans, including new PET machines and FastScan technology.

Original reporting
fool.com
Published Aug 20, 2026, 12:45 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 20, 2026, 1:07 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Lumexa Imaging (LMRI) Q2 2026 Earnings Call Transcript — source image
Source · fool.com
Decision brief

The 30-second read

$LMRIBullishHigh
01

Why it matters

Earnings beat and tighter guidance suggest near‑term upside, but execution of expansion plans and regulatory reimbursement changes remain key risks.

02

Market read

First report of Q2 earnings provides fresh data for traders; impacts LMRI stock and related healthcare imaging sector.

03

What to watch

Potential payer mix shifts and CMS site‑neutral reimbursement uncertainty could pressure margins.

Relevance 8/10Novelty 8/10Timing: post‑earnings release

Background

Lumexa Imaging reported Q2 2026 results, highlighting revenue growth, margin improvement, and new joint‑venture initiatives.

Company-level read

Ticker impact

$LMRIBullishHigh confidence
Context

Q2 2026 earnings disclosed revenue of $264.2M, net income $2.7M, and narrowed full-year adjusted EBITDA guidance.

Expected impact

Potential short-term price rally on earnings beat and guidance upgrade.

Evidence & confidence

First disclosure of quarterly results with better-than-expected earnings and tighter guidance provides fresh actionable information.

Market effects

Sector

Strong performance may lift the independent diagnostic imaging sector and related equipment suppliers.

Regional

Positive for U.S. healthcare services investors.

Global

Limited to U.S. healthcare and imaging markets.

Counterpoint

What could challenge this read

Higher leverage reduction may be offset by rising interest expense volatility and execution risk of joint‑venture expansions.

Key entities

  • company
    Lumexa Imaging Holdings, Inc.

    Provider of independent diagnostic imaging services.

  • partner
    Hospital for Special Surgery

    Joint‑venture partner announced in the earnings call.

Read at source← All news

Related articles

AUG 12
$LMRIMed

Lumexa Imaging Holdings, Inc. (LMRI): Results of Operations and Financial Condition

Lumexa Imaging Holdings, Inc. (LMRI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Lumexa Imaging Announces Second Quarter 2026 Results RALEIGH, N. C., August 12, 2026—Lumexa Imaging (Nasdaq: LMRI), one of the nation’s largest providers of outpatient imaging services, today reported results for the second quarter ended June 30, 2026, and updated it

SEC EDGAR 8-K6 min
JUN 2
$LMRIMed

Lumexa Imaging Announces Joint Venture with Hospital for Special Surgery (HSS) to Expand Advanced Outpatient Imaging in New York

Lumexa Imaging (NASDAQ: LMRI) said it formed a strategic joint venture with Hospital for Special Surgery (HSS) to expand advanced outpatient imaging across the New York City metro area. The deal is Lumexa’s ninth joint venture and supports its growth strategy via de novo development, acquisitions, and partnerships. Lumexa reported about 4 million outpatient procedures system-wide in 2025.

manilatimes.net4 min
SEP 19
$GMMed

Top analyst strongly resets General Motors target before earnings

UBS raised its price target for General Motors (GM) to $114 from $102, citing undervalued digital capabilities. Analyst Joseph Spak highlights GM's software business, expecting revenue to grow from $3.2B to $9.6B by 2036. GM's digital business contributes significantly to operating profit. GM's earnings report is due Oct. 20.

yahoo.com2 min
SEP 19
$BACHigh

Jim Cramer Remains Optimistic About Bank of America Corporation (NYSE:BAC) After Recent Drop

Bank of America (BAC) shares fell 5% after CEO Brian Moynihan projected lower investment banking revenue. Jim Cramer deemed the reaction excessive, citing a minor EPS cut. BAC's Q2 revenue grew 50% YoY, with net income up 27%. The bank trades at a forward P/E of 11.43, similar to peers. Hedge funds increased stakes, with Azora Capital and Marshall Wace LLP notable additions.

insidermonkey.com2 min
SEP 19
$SPCXHighAI 8/10

Musk Calls $10 Trillion in Starship Revenue ‘Not Impossible.’ Here Are 2 Things You Need to Know About His Bold Projection.

SpaceX (SPCX) reported Q2 2026 revenue of $7.8B, up 92% YOY, with AI segment revenue at $2.6B. Management targets $100B annualized revenue run rate by year-end. Analysts remain bullish, with Goldman Sachs and Morgan Stanley setting price targets of $220 and $300, respectively. The stock has fallen 10% since June 2026 but remains above its IPO price of $135.

yahoo.com2 min
SEP 19
$PYPLMed

9.50x Earnings: Is PayPal the Cheapest Stock in Fintech, or a Trap?

PayPal (PYPL) closed at $52.71 on September 16, 2026, near pre-takeover speculation levels. Free cash flow margin rebounded to 20.44% in Q2 2026. Analysts' buy ratings have decreased, while hold ratings increased. CEO guided Q3 branded checkout down to 1-2%, citing European tariff impacts. PYPL's NTM P/E is 9.50x, below its 3-year mean of 12.67x.

yahoo.com3 min